AcuCort’s drug ISICORT® is approved for treatment of COVID-19
AcuCort AB (Spotlight Stock Market: ACUC) today announced that the Swedish Medical Products Agency has granted the company’s drug ISICORT® the indication - treatment of coronavirus disease 2019 (COVID-19) in adults and adolescents who need supplemental oxygen treatment.In October 2020, ISICORT® received marketing approval in Sweden by the Swedish Medical Products Agency (MPA) for the indications, among others, for the treatment of severe and acute allergic reactions, croup in children, as well as chemotherapy-induced nausea and vomiting (CINV). Based on published positive results from